These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6217723)

  • 1. Paroxetine: pharmacokinetics and cardiovascular effects after oral and intravenous single doses in man.
    Lund J; Thayssen P; Mengel H; Pedersen OL; Kristensen CB; Gram LF
    Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):351-7. PubMed ID: 6217723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine: pharmacokinetics, tolerance and depletion of blood 5-HT in man.
    Lund J; Lomholt B; Fabricius J; Christensen JA; Bechgaard E
    Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):289-95. PubMed ID: 433623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration.
    Heykants J; Hendriks R; Meuldermans W; Michiels M; Scheygrond H; Reyntjens H
    Eur J Drug Metab Pharmacokinet; 1981; 6(1):61-70. PubMed ID: 7250152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetics of citalopram: single and multiple dose studies in man.
    Kragh-Sørensen P; Overø KF; Petersen OL; Jensen K; Parnas W
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):53-60. PubMed ID: 6939299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of the 5-HT2 receptor antagonist ketanserin in man.
    Trenk D; Mosler A; Kirch W; Meinertz T; Jähnchen E
    J Cardiovasc Pharmacol; 1983; 5(6):1034-9. PubMed ID: 6196551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humans.
    Nielsen-Kudsk F; Jensen TS; Magnussen I; Jakobsen P; Jensen PB; Mondrup K; Petersen T
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):121-7. PubMed ID: 6133404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
    Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
    J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
    Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
    Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the pharmacodynamics and pharmacokinetics of 2-(2,4-dimethoxyphenyl)-Imidazo-(4,5-b)-pyridine hydrochloride (AR-L 57 CL) in man.
    Belz GG; Nübling H; Zimmer A
    Eur J Clin Pharmacol; 1976 Sep; 10(5):319-24. PubMed ID: 976305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG; Kirsten EB
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ketanserin in man.
    Reimann IW; Okonkwo PO; Klotz U
    Eur J Clin Pharmacol; 1983; 25(1):73-6. PubMed ID: 6617728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamics, biochemical effects, and pharmacokinetics of the renin inhibitor remikiren in healthy human subjects.
    Kleinbloesem CH; Weber C; Fahrner E; Dellenbach M; Welker H; Schröter V; Belz GG
    Clin Pharmacol Ther; 1993 May; 53(5):585-92. PubMed ID: 8491068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker.
    Carruthers SG; Pentikainen P; Hosler JP; Azarnoff DL
    Clin Pharmacol Ther; 1979 Dec; 26(6):682-5. PubMed ID: 40725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.